Net Cash Provided by (Used in) Financing Activities of Lunai Bioworks Inc. from 31 Mar 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lunai Bioworks Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2011 to 30 Sep 2025.
  • Lunai Bioworks Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $1,343,357, a 34% decline year-over-year.
  • Lunai Bioworks Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $8,382,772, a 20% decline from 2024.
  • Lunai Bioworks Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,517,455, a 133% increase from 2023.
  • Lunai Bioworks Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,515,056, a 6.2% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Lunai Bioworks Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,343,357 -$685,826 -34% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q3 2024 $2,029,183 -$533,634 -21% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q1
Q3 2023 $2,562,817 +$1,104,442 +76% 01 Jul 2023 30 Sep 2023 10-Q/A 19 Feb 2025 2025 Q1
Q3 2022 $1,458,375 +$1,458,375 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q3 2021 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q3 2020 $0 -$1,000,000 -100% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q1
Q3 2019 $1,000,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q3 2017 $4,499 -$365,399 -101% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2019 Q1
Q3 2016 $360,900 29 Jun 2016 30 Sep 2016 10-Q 14 Nov 2016 2017 Q1
Q3 2014 $529,589 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2016 Q1
Q1 2014 $865,976 -$121,935 -12% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015 2015 Q1
Q2 2013 $500* -$10,500 01 Apr 2013 30 Jun 2013 10-Q 15 Aug 2013 2013 Q1
Q1 2013 $987,911 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q2 2012 $11,000 +$6,000 +120% 01 Apr 2012 30 Jun 2012 10-Q 15 Aug 2013 2013 Q1
Q2 2011 $5,000 01 Apr 2011 30 Jun 2011 10-Q 20 Aug 2012 2012 Q1
Q1 2011 $0 18 Jan 2011 31 Mar 2011 10-K 17 Jul 2012 2011 FY

Lunai Bioworks Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $8,382,772 -$2,134,683 -20% 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
2024 $10,517,455 +$6,002,399 +133% 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025 2025 FY
2023 $4,515,056 +$264,592 +6.2% 01 Jul 2022 30 Jun 2023 10-K/A 19 Feb 2025 2024 FY
2022 $4,250,464 -$28,351,089 -87% 01 Jul 2021 30 Jun 2022 10-K 02 Oct 2023 2023 FY
2021 $32,601,553 +$25,401,553 +353% 01 Jul 2020 30 Jun 2021 10-K 27 Feb 2023 2022 FY
2020 $7,200,000 +$1,180,000 +20% 01 Jul 2019 30 Jun 2020 10-K 24 Sep 2021 2021 FY
2019 $6,020,000 -$10,692,715 -64% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020 2020 FY
2018 $16,712,715 +$11,206,114 +204% 01 Jul 2017 30 Jun 2018 10-K 30 Sep 2019 2019 FY
2017 $5,506,601 01 Jul 2016 30 Jun 2017 10-K 01 Oct 2018 2018 FY
2014 $6,669,807 +$4,200,281 +170% 01 Jan 2014 31 Dec 2014 10-K 28 Sep 2016 2016 FY
2013 $2,469,526 +$1,612,772 +188% 01 Jan 2013 31 Dec 2013 10-KT 28 Sep 2015 2015 FY
2012 $856,754 +$823,254 +2457% 01 Jan 2012 31 Dec 2012 10-Q 14 Aug 2014 2014 Q2
2011 $33,500 19 Jan 2011 31 Dec 2011 10-Q 21 Feb 2012 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.